Ocrelizumab May Reduce Disability Progression in People With Primary Progressive MSOctober 6, 2015Multiple Sclerosis
Daclizumab HYP May Improve Ambulation and Cognition, Compared With Interferon β-1aJune 1, 2015Multiple Sclerosis